Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clinical next generation sequencing to identify actionable aberrations in a phase I program.

Clinical next generation sequencing to identify actionable aberrations in a phase I program. Oncotarget. 2015 Aug 21; 6(24):20099-110.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.